User: I want to know more about the compound with SMILES Nc1nccc(-c2ccc(O)c(-c3ccnc(N)n3)n2)n1.
Assistant: Sure, what is your question?
User: Please describe this drug.
Assistant: The answer is Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
User: I want to know more about the {#molecule|chemical|compound!} with {SMILES__description} {SMILES#}.
Assistant: {#Sure, what is your question?|How can I help?|That sounds interesting, how can I help?|Interesting, how can I help?!}
User: {quest#}
Assistant: {#The answer is |!}{answ#}
Nc1nccc(-c2ccc(O)c(-c3ccnc(N)n3)n2)n1
C1=CC(=NC(=C1O)C2=NC(=NC=C2)N)C3=NC(=NC=C3)N
2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol
Please describe this drug.
Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).